Heart Disease
Showing 8 of 36 results

GLP-1 Agonists for Weight Loss - Preserving Muscle Mass in the Pursuit of Metabolic Health
Learn more about the latest research findings on GLP-1 and muscle health, as well as strategies for balancing fat loss with muscle preservation.

2025 Medicare Roadmap - Navigating Drug Coverage Changes
Learn how these 2025 Medicare changes may affect pharmacies, healthcare providers and prescription access going forward.

Hypertrophic Cardiomyopathy (HCM) - The Patient Perspective
A few of our patients share their personal HCM journey and experience with treatment, from medical therapies to septal myectomy.

Beyond the Buzz - Alcohol's Effects on Cardiometabolic Health
Learn about the relationship between alcohol and key cardiometabolic risk factors.

Heartfelt Conversations - Supporting siblings of children with CHD
Learn more about how siblings of children with congenital heart disease are affected by their siblings’ chronic illness.

Sleep Apnea Risk in Cardiovascular Disorders
Learn more about sleep apnea types, mechanisms, and clinical epidemiology.

Obesities and Cardiometabolic Diseases - Importance of Lifestyle Vital Signs
Learn about the importance of visceral adiposity and ectopic fat depots as key drivers of health risk in obesity and relevance of targeting key "lifestyle vital signs".

Update on Drug Therapies for Obesity
Learn the key treatment principles regarding use of anti-obesity medications, including nutrient-stimulated hormone (NuSH)-based therapies and strategies to reduce gastrointestinal (GI) side effects.